Loading people...
Inés Simó is currently a Venture Analyst at Apollo Health Ventures, a prominent transatlantic venture capital firm operating primarily out of investment hubs in Berlin, Germany, and Boston, Massachusetts. In this analytical capacity, she specializes in sourcing, structuring, and evaluating early-stage healthcare investments distributed across the biotechnology, digital health, and broader life sciences sectors. Simó contributes directly to the firm's core investment strategy by analyzing emerging medical technologies and actively supporting portfolio companies backed by Apollo Health Ventures' $180 million second fund. Her specific domain expertise centers on the intersection of health information technology and longevity therapeutics, with a highly targeted emphasis on novel treatments for complex aging-related diseases. Operating actively within the global venture capital ecosystem as of 2024, Simó maintains a primary professional focus on identifying, funding, and scaling innovative early-stage biotechnology enterprises.
Inés Simó is a dedicated Analyst at Apollo Health Ventures, a prominent venture capital firm at the forefront of health innovation. In her pivotal role, Inés contributes significantly to the firm's investment strategy, focusing on identifying and nurturing the next generation of groundbreaking companies in the health sector. Apollo Health Ventures is renowned for its commitment to investing in deep tech and science-driven innovation, particularly within the burgeoning field of longevity biotech and solutions for age-related diseases.
As an Analyst, Inés Simó's responsibilities are multifaceted. She plays a crucial part in the initial screening and evaluation of potential investment opportunities. This involves extensive market research, competitive analysis, and a deep dive into the scientific and technological merits of various early-stage ventures. Her analytical acumen is vital in assessing the commercial viability and long-term impact of innovative health solutions. Inés works closely with the senior investment team, providing critical insights that inform investment decisions and help shape the firm's portfolio.
Apollo Health Ventures' investment thesis centers on supporting companies that are developing transformative technologies to extend healthy human lifespan and address the root causes of age-related conditions. Inés Simó's work directly aligns with this mission, as she helps uncover startups that are pushing the boundaries of biotechnology, pharmaceuticals, diagnostics, and digital health. Her focus areas likely include novel therapeutics, advanced diagnostics, and preventative health technologies designed to combat diseases associated with aging, such as neurodegeneration, cardiovascular disease, and metabolic disorders.
While specific details of Inés Simó's career background are not publicly detailed, her position as an Analyst at Apollo Health Ventures suggests a strong foundation in scientific research, finance, or a related analytical field. Professionals in this role typically possess a keen understanding of complex scientific concepts, coupled with robust financial modeling and due diligence skills. Her passion for healthcare innovation and her commitment to supporting entrepreneurial endeavors are undoubtedly key drivers in her contributions to Apollo Health Ventures' success. Inés Simó is an integral part of the team driving forward investments that aim to revolutionize health and well-being globally, making significant contributions to the venture capital landscape in health.
Inés Simó is an Analyst at Apollo Health Ventures, a venture capital firm specializing in health innovation and longevity biotech.
As an Analyst at Apollo Health Ventures, Inés Simó contributes to investments in early-stage companies focused on longevity biotech, age-related diseases, and deep tech within the health sector.
Inés Simó works as an Analyst at Apollo Health Ventures, a leading venture capital firm dedicated to advancing health innovation.
